-0.29%
-2.86%
-7.94%
-18.94%
-8.93%
-11.94%
48.87%
AI Spotlight on DHR
Company Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions.The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers.The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products.This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings.
The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications.This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products.The company was formerly known as Diversified Mortgage Investors, Inc.
and changed its name to Danaher Corporation in 1984.Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Market Data
| Last Price | 223.08 |
| Change Percentage | -0.29% |
| Open | 225 |
| Previous Close | 223.73 |
| Market Cap ( Millions) | 161125 |
| Volume | 6091141 |
| Year High | 281.7 |
| Year Low | 221.34 |
| M A 50 | 235.68 |
| M A 200 | 253.43 |
Financial Ratios
| FCF Yield | 3.29% |
| Dividend Yield | 0.48% |
| ROE | 7.64% |
| Debt / Equity | 32.31% |
| Net Debt / EBIDTA | 206.26% |
| Price To Book | 3.25 |
| Price Earnings Ratio | 41.35 |
| Price To FCF | 30.42 |
| Price To sales | 6.75 |
| EV / EBITDA | 25.93 |
News
- Jan -30 - Danaher Analysts Cut Their Forecasts After Downbeat Earnings
- Jan -29 - Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y
- Jan -29 - Danaher (DHR) Reports Q4 Earnings: What Key Metrics Have to Say
- Jan -29 - Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript
- Jan -29 - Danaher (DHR) Lags Q4 Earnings Estimates
- Jan -29 - Danaher misses quarterly profit estimates on weak biotech demand
- Jan -29 - Danaher Reports Fourth Quarter and Full Year 2024 Results
- Jan -28 - MARUY vs. DHR: Which Stock Should Value Investors Buy Now?
- Jan -24 - Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?
- Jan -22 - Danaher (DHR) Earnings Expected to Grow: Should You Buy?
- Jan -21 - Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade Applications
- Jan -16 - Danaher: Transition Year Recap
- Jan -16 - The Near-Perfect Dividend Portfolio With 10 Sleep-Well-At-Night Gems
- Jan -15 - Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research
- Jan -14 - Danaher Corporation (DHR) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
- Jan -13 - Danaher CEO to Comment on Financial Performance
- Jan -13 - Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth
- Jan -09 - Danaher Announces Investment Partnership in Innovaccer Inc.
- Jan -06 - Danaher to Present at J.P. Morgan Healthcare Conference
- Jan -06 - Danaher: A Wide-Moat Gem I Cannot Buy Enough Of
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Diagnostics
Expected Growth : 4.5 %
What the company do ?
Diagnostics from Danaher Corporation provides innovative diagnostic instruments, reagents, and software to detect and treat diseases, improving healthcare outcomes.
Why we expect these perspectives ?
Danaher Corporation's Diagnostics segment growth of 4.5% is driven by increasing demand for molecular diagnostics, expansion in emerging markets, and strategic acquisitions. Additionally, the company's focus on innovation, such as its Beckman Coulter and Cepheid brands, has led to market share gains and revenue growth.
Segment n°2 -> Biotechnology
Expected Growth : 4.8 %
What the company do ?
Danaher Corporation's Biotechnology segment provides life science research and clinical diagnostic products, including microscopes, gene editing tools, and bioprocessing equipment.
Why we expect these perspectives ?
Danaher Corporation's Biotechnology segment growth of 4.8% is driven by increasing demand for life sciences research tools, expansion in emerging markets, and strategic acquisitions. Additionally, the company's focus on innovation, particularly in areas like genomics and gene editing, has contributed to its growth. Furthermore, the rising need for bioprocessing and biomanufacturing solutions has also fueled the segment's growth.
Segment n°3 -> Life Sciences
Expected Growth : 5.2 %
What the company do ?
Life Sciences from Danaher Corporation provides innovative biotechnological tools and services to support scientific research, diagnostics, and therapeutic development.
Why we expect these perspectives ?
Danaher's Life Sciences segment growth of 5.2% is driven by increasing demand for biotechnology research tools, expansion in emerging markets, and strategic acquisitions. Additionally, the segment benefits from growing adoption of genomics and proteomics technologies, as well as investments in research and development to stay ahead in the competitive landscape.
Danaher Corporation Products
| Product Range | What is it ? |
|---|---|
| Life Sciences | Provides bioprocessing, discovery, and analytical solutions to help develop and manufacture biologics, vaccines, and medicines. |
| Diagnostics | Offers diagnostic instruments, reagents, and software to help diagnose and monitor diseases, including COVID-19. |
| Dental | Provides dental consumables, equipment, and digital dentistry solutions to help dental professionals improve patient care. |
| Environmental & Applied Solutions | Offers instruments, software, and services to help monitor and improve environmental quality, as well as provide solutions for industrial and applied markets. |
Danaher Corporation's Porter Forces
Threat Of Substitutes
Danaher Corporation operates in a industry with moderate threat of substitutes. The company's products and services are differentiated, but customers have some alternatives.
Bargaining Power Of Customers
Danaher Corporation's customers have low bargaining power due to the company's diversified product portfolio and strong brand recognition.
Bargaining Power Of Suppliers
Danaher Corporation's suppliers have moderate bargaining power due to the company's dependence on a few key suppliers for certain components.
Threat Of New Entrants
The threat of new entrants is low for Danaher Corporation due to the high barriers to entry in the industry, including significant capital requirements and regulatory hurdles.
Intensity Of Rivalry
The intensity of rivalry is high in Danaher Corporation's industry, with several established players competing for market share.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 26.75% |
| Debt Cost | 3.95% |
| Equity Weight | 73.25% |
| Equity Cost | 8.22% |
| WACC | 7.08% |
| Leverage | 36.53% |
Danaher Corporation : Quality Control
Danaher Corporation passed 7 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| IQV | IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: … |
| MTD | Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and … |
| A | Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; … |
| IDXX | IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; … |
| TMO | Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Mettler-Toledo
A-Score
1-Year Total Return ->
🥈
Thermo Fisher
A-Score
1-Year Total Return ->
🥉
Danaher
A-Score
1-Year Total Return ->
4
Agilent Technologies
A-Score
1-Year Total Return ->
5
IQVIA
A-Score
1-Year Total Return ->
6
